To study radiotherapy-related adverse effects, detailed dose information (3D distribution) is needed for accurate dose-effect modeling. For childhood cancer survivors who underwent radiotherapy in the pre-CT era, only 2D radiographs were acquired, thus 3D dose distributions must be reconstructed from limited information. State-of-the-art methods achieve this by using 3D surrogate anatomies. These can however lack personalization and lead to coarse reconstructions. We present and validate a surrogate-free dose reconstruction method based on Machine Learning (ML). Abdominal planning CTs (n = 142) of recently-treated childhood cancer patients were gathered, their organs at risk were segmented, and 300 artificial Wilms' tumor plans were sampled automatically. Each artificial plan was automatically emulated on the 142 CTs, resulting in 42,600 3D dose distributions from which dose-volume metrics were derived. Anatomical features were extracted from digitally reconstructed radiographs simulated from the CTs to resemble historical radiographs. Further, patient and radiotherapy plan features typically available from historical treatment records were collected. An evolutionary ML algorithm was then used to link features to dosevolume metrics. Besides 5-fold cross validation, a further evaluation was done on an independent dataset of five CTs each associated with two clinical plans. Crossvalidation resulted in mean absolute errors ≤0.6 Gy for organs completely inside or outside the field. For organs positioned at the edge of the field, mean absolute errors ≤1.7 Gy for D mean , ≤2.9 Gy for D 2cc , and ≤13% for V 5Gy and V 10Gy , were obtained, without systematic bias. Similar results were found for the independent dataset. To conclude, we proposed a novel organ dose reconstruction method that uses ML models to predict dose-volume metric values given patient and plan features. Our approach is not only accurate, but also efficient, as the setup of a surrogate is no longer needed.
Abstract. To study radiotherapy-related adverse effects, detailed dose information (3D distribution) is needed for accurate dose-effect modeling. For childhood cancer survivors who underwent radiotherapy in the pre-CT era, only 2D radiographs were acquired, thus 3D dose distributions must be reconstructed from limited information. State-of-the-art methods achieve this by using 3D surrogate anatomies. These can however lack personalization and lead to coarse reconstructions. We present and validate a surrogate-free dose reconstruction method based on Machine Learning (ML). Abdominal planning CTs (n = 142) of recently-treated childhood cancer patients were gathered, their organs at risk were segmented, and 300 artificial Wilms' tumor plans were sampled automatically. Each artificial plan was automatically emulated on the 142 CTs, resulting in 42,600 3D dose distributions from which dose-volume metrics were derived. Anatomical features were extracted from digitally reconstructed radiographs simulated from the CTs to resemble historical radiographs. Further, patient and radiotherapy plan features typically available from historical treatment records were collected. An evolutionary ML algorithm was then used to link features to dosevolume metrics. Besides 5-fold cross validation, a further evaluation was done on an independent dataset of five CTs each associated with two clinical plans. Crossvalidation resulted in mean absolute errors ≤0.6 Gy for organs completely inside or outside the field. For organs positioned at the edge of the field, mean absolute errors ≤1.7 Gy for D mean , ≤2.9 Gy for D 2cc , and ≤13% for V 5Gy and V 10Gy , were obtained, without systematic bias. Similar results were found for the independent dataset. To conclude, we proposed a novel organ dose reconstruction method that uses ML models to predict dose-volume metric values given patient and plan features. Our approach is not only accurate, but also efficient, as the setup of a surrogate is no longer needed.
Introduction
Patients undergoing radiotherapy (RT) are prone to develop radiation-related Adverse Effects (AEs) (Birgisson et al 2005 , van Dijk et al 2010 , Cheung et al 2017 . To improve the design of future multi-modality treatments, clinicians are interested in better understanding the relationship between radiation dose and onset of AEs. Modern research efforts in this direction delve into dosimetric details, employing dose distribution metrics to a specific organ (or sub-volume) as explanatory variables. Such rich information is obtained by simulating the RT plan on 3D imaging of the patient (i.e., CT scans) with organ segmentations in a Treatment Planning System (TPS) (Donovan et al 2007 , Feng et al 2007 , Bölling et al 2011 .
Unfortunately, when so-called late AEs (onset can be decades after RT) need to be studied, it is not always possible to straightforwardly obtain detailed information on dose distributions (Birgisson et al 2005) . For patients who underwent RT before the use of planning CTs became commonplace (in the following, historical patients), 2D radiographs were used for treatment planning (e.g., this was the case until the 1990s in the Netherlands (van Dijk et al 2010)), meaning no 3D anatomical imaging is available. Consequently, no simulations can be performed in a TPS to estimate 3D dose distributions for these patients (Stovall et al 2006 , Verellen et al 2008 , Ng et al 2012 . The information available for historical patients normally consists of what was reported in treatment records, e.g., features of the patient such as age and gender, and features of the plan such as prescribed dose, geometry of the plan, and the use of blocks. Additionally, 2D radiographs can be available, from which information can be gathered on the internal anatomy (mainly bony anatomy, as internal organs are normally not clearly distinguishable), and on the plan configuration with respect to the patient's anatomy (Leisenring et al 2009 , van Dijk et al 2010 .
To improve the understanding of late AEs, recent research is striving to develop increasingly accurate dose reconstruction methods, i.e., methods to estimate the 3D dose distribution received by historical patients (Stovall et al 2006 , Ng et al 2012 , Xu 2014 , Lee et al 2015 . State-of-the-art approaches employ phantoms, i.e., 3D surrogates of the human anatomy upon which the RT plan can be simulated, to compute the dose distribution. Phantoms exist in different forms: physical or virtual, made by simple geometrical shapes or by adopting and morphing actual CT scans and organ segmentations (Stovall et al 2006 , Xu 2014 , Lee et al 2015 . Generally, phantoms are built to represent average anatomies, for categories of patients (e.g., for a certain age range), and are collected into so-called phantom libraries (Cassola et al 2011 , Segars et al 2013 , Geyer et al 2014 . Whenever dose reconstruction for a historical patient is needed, the phantom that represents the category that the patient belongs to is retrieved from the library and used as surrogate for simulation of the RT plan.
As the largest source of error related to phantom-based dose reconstruction comes from the mismatch between the anatomy of the phantom and the true anatomy of the patient (Bezin et al 2017) , it is important to define the best way to match phantoms to patients. This issue is still under research, and different approaches employ different heuristic matching criteria that are normally hand-crafted and based upon statistics and guidelines drawn from large population studies (e.g., ICRP89, NANTHES) (Valentin 2002 , Cassola et al 2011 , Segars et al 2013 , Geyer et al 2014 . However, the use of heuristic matching criteria has been hypothesized to be too simplistic to capture the high variability of internal human anatomy (de la Grandmaison et al 2001 , Geyer et al 2014 , Xu 2014 , Virgolin et al 2018b . For example, a popular phantom-based dose reconstruction approach uses solely age and gender for surrogate matching (Howell et al 2019) . Our group's recent work focusing on Wilms' tumor (the most common type of kidney cancer for childhood cancer patients) irradiation for pediatric patients showed that utilizing surrogate CTs using age-and genderbased matching can lead to poor dose reconstruction quality in individual cases (Wang et al 2018) .
To improve the resemblance of a surrogate phantom, there have been efforts to replace the normally hand-crafted heuristic matching criteria with data-driven decisions. For example, statistical models inferred from CTs and 3D organ segmentations of adult patients have been used to drive a deformable image registration procedure that adapted 3D organ segmentations to the 2D anatomy of a specific patient, given features of the latter as measurable from 2D radiographs (Ng et al 2012 , Mishra et al 2013 . Using a state-of-the-art Machine Learning (ML) algorithm, it has been shown that features typically available for historical patients treated for Wilms' tumor can be linked to different 3D anatomy similarity metrics based on organ segmentations and CTs (Virgolin et al 2018b) . Our group recently proposed an automatic pipeline that uses ML to steer the assembling of a new original anatomy based on 3D CTs and organ segmentations of multiple patients using the features of a historical patient , Virgolin et al 2020b . However, it is important to realize that maximizing some form of overall anatomical resemblance is difficult. Moreover, from the standpoint of optimizing dose reconstruction accuracy, it can be considered sub-optimal for RT dosimetry purposes. This is because in RT dosimetry, what part of anatomy is most meaningful largely depends on the particular RT plan .
To the best of our knowledge, although both patient anatomy and plan geometry play a key role in determining dose-volume metrics for Organs At Risk (OARs), existing dose reconstruction approaches focused solely on patient anatomy information, to obtain a representative surrogate. Plan information is used only later, to calculate the dose on the surrogate. The purpose of this article is to develop and validate an ML approach to predict dose-volume metrics for OARs based on patient anatomy and plan geometry information. Specifically, we propose to use ML to directly learn what dose-volume metrics for an OAR are likely given information on the patient and on the plan, without the need to select or craft any surrogate anatomy. We argue that this is a sensible choice because ML can directly be trained upon what ultimately matters, i.e., dose reconstruction accuracy. In this article we present our ML-based organ dose reconstruction approach and its validation, that was performed on a relatively large dataset of artificial plans, as well as on a smaller dataset of clinical plans.
Materials & Methods
We considered pediatric flank RT, and in particular RT for Wilms' tumor, as an application for our dose reconstruction method, in continuity with our previous work. The choice to focus on pediatrics is because children are the most prone to develop late AEs (Cheung et al 2017) , and are typically underrepresented in existing phantom libraries (Xu 2014) . Moreover, more than 85% of pediatric patients survives Wilms' tumor five years or longer, but considerable chances of the onset of late AEs remain (van Dijk et al 2010).
Patient data
To be able to create a ground-truth to learn dose-volume metrics from, CT scans were needed. Hence, a total of 142 pediatric planning CTs were collected by involving the following institutes (number of CTs in brackets): Amsterdam University Medical Centers / Emma Children's Hospital (n = 38), University Medical Center Utrecht / Princess Máxima Center for Pediatric Oncology (n = 42), The Christie NHS Foundation Trust (n = 33), Princess Margaret Cancer Centre (n = 18), and Institute of Oncology Ljubljana (n = 11). Five further CTs were collected from the Amsterdam University Medical Centers and kept aside to be used exclusively for an additional validation step (Sec. 2.5).
The inclusion criteria were: patient age at scan acquisition between 1 to 8 years; the CT field of view including a common abdominal region from the tenth thoracic (T10) vertebral body to the first sacral (S1) vertebral body; presence of five lumbar vertebrae (rare cases of patients with six exist); patient scanned in supine position; quality of CT sufficient to perform organ segmentations. The patients underwent RT between 2002 and 2018, mostly but not exclusively for abdominal cancers. The median CT slice resolution was 0.94 × 0.94 mm, the median slice thickness was 3 mm.
As we focused on Wilms' tumor treatment, four OARs were considered: the liver, the spleen, the contralateral kidney (left or right, depending on the side of the tumor), and the spinal cord (between T10 and S1). To provide accurate and consistent OAR segmentations, we carefully prepared the OAR segmentations in all CTs (n = 142 + 5): for 60 CTs, pre-existing clinical segmentations of OARs were manually improved and approved (I.W.E.M. van Dijk, checked by B.V. Balgobind only for difficult cases). To aid the manual segmentation of the OARs for the remaining CTs (n=87), the software ADMIRE (research version 2.3.0) from Elekta (Elekta AB, Stockholm, Sweden) was used to generate multi-atlas based automatic segmentations using the previous 60 CTs as atlas. These segmentations were further manually checked slice-by-slice and possibly adapted (Z. Wang, I.W.E.M. van Dijk), and finally checked and approved (I.W.E.M. van Dijk, checked by B.V. Balgobind only for difficult cases). Some patients did not have both kidneys intact, due to nephrectomy prior to RT. The number of CTs that had only a complete right kidney, only a complete left kidney, and two complete kidneys were 36, 40, and 71, respectively.
Automatic generation of artificial Wilms' tumor plans
A method to automatically generate historical-like abdominal flank irradiation plans (i.e., artificial plans) for Wilms' tumor treatment based on information visible on 2D radiographs was created, in order to obtain large plan variations.
Figures 1(a) and 1(c) illustrate examples of actual historical plans on respective historical radiographs. As can be observed from the examples, a typical historical flank irradiation field is a rectangular area, with possible shielding blocks, that is located on the right or on the left flank. Flank irradiation is done by beams from anterior-posterior (AP) and posterior-anterior (PA) direction. Along right-left (RL), one field border is located at the edge of the patient's body contour, while the other is located as to include the vertebral column (van den Heuvel-Eibrink et al 2017). In some cases, blocks were placed to protect OARs from irradiation ( Fig. 1(c) ). In historical plans the isocenter was positioned in the center of the treatment field that is projected on the coronal plane ( Fig. 1 ) and at the middle of the patient's AP abdominal diameter.
To generate artificial plans, two reference digitally reconstructed radiographs (DRRs) were considered, randomly selected from the data. One DRR was derived from a CT of a 5-year old female patient without nephrectomy (ref 1 in Fig. 2 ), and the other was derived from a CT of a 4-year old female patient with nephrectomy of the left kidney (ref 2 in Fig. 2 ). Upon these two DRRs, boundaries defining plan variability were identified by an experienced pediatric radiation oncologist (B. V. Balgobind), to ensure that generated plans would appear to be reasonable according to historical clinical guidelines. Note that historical clinical guidelines are slightly different from current ones (e.g., currently the iliac crests should be safeguarded, unlike in Fig. 1(c) ). Figure 2 shows two examples of landmark locations identifying possible plan variations, on the two reference DRRs. Specifically, given the boundaries of possible isocenter positions and field borders, plans with a rectangular field were generated by sampling uniformly within those boundaries. For each plan generated, an additional version of that plan including one block was generated as well. A block was simulated as the area in the upper lateral corner enclosed by the border of the rectangular field and a line crossing two randomly sampled endpoints. The endpoints were sampled from two regions roughly covering the start and end points of rib 9 and rib 12 on the DRRs (regions indicated by the green boxes in Fig. 2 ). This way, a sampled block covered part of the liver (in right-sided plans) or part of the spleen (in left-sided plans). All plans consist of two opposing and symmetrical beams in AP-PA directions irradiating one side of the abdominal flank. A total of 300 artificial plans were generated automatically, of which 150 without a block, and 150 with a block. The random sampling of the plan side led to 142 left-sided plans and 158 right-sided plans (roughly half-half). The same set of plan features used in our previous work was considered to generate plans in DICOM RTPLAN format (e.g., gantry and collimator angles, isocenter location, field sizes) (Wang et al 2020) . Figure 3 summarizes the pipeline used to generate the dataset for ML. Firstly, we emulated each of the 300 artificial plans on each of the 142 CT scans by the automatic plan emulation method proposed in our previous work (Wang et al 2020) , leading to a total of 42,600 emulations. The method automatically transfers a plan prepared on one CT to another CT (with quality comparable to human experts), using landmark detection upon the respective DRRs. Secondly, for each of the 42,600 plan emulations, dose-volume metrics of interest (see Sec. 2.3.1) were collected for the different OARs by use of our automatic dose computation pipeline (Wang et al 2020) . The pipeline used the collapsed cone dose calculation algorithm of Oncentra TPS (version 4.3, Elekta AB, Stockhom, Sweden). Thirdly, features that are plausible to be available for typical historical cases were collected from the anatomy of the included CTs as visible in the respective DRRs, from the artificial plans, and from the relationship between anatomy and plan geometry.
Generation of the dataset for ML

Response variables: dose-volume metrics
To select dose-volume metrics to use as response variables for ML, we considered metrics typically used to validate state-of-theart dose reconstruction approaches ( The explanatory and response variables are used as input to train the ML model. The explanatory variables include features of the plan (e.g., isocenter location, field size), patient features (e.g., age, nephrectomy), and features on the relationship between the anatomy of the patient and the geometry of the plan (e.g., signed distance between the 2 nd lumbar vertebra and the plan isocenter). The response variables are dose-volume metrics for each OAR.
to be of clinical relevance in studies of AEs in adults (e.g., QUANTEC) (Leisenring et al 2009 , Bölling et al 2011 , Emami et al 1991 . Studies on dose-volume response relationships for pediatric patients (so-called PENTEC studies (Constine et al 2019) ) are currently limited. This reasoning led us to consider mean organ dose (D mean ), two levels of percentage of OAR volume receiving at least X Gy (V XGy ), and the minimum dose received by the maximally exposed 2 cubic centimeters of an OAR (D 2cc ), the latter being similar but more robust than the maximum dose to a single point. Typically, V 5Gy and V 20Gy are considered. However, instead of V 20Gy , we decided to use V 10Gy in this work since our plans have a prescribed dose of 14.4 Gy (thus V 20Gy was always 0 for the OARs). Regarding D 2cc , we decided to include this metric because peak dose values to a small OAR portion may be relevant to explain late AEs related to OARs that work in a serial fashion (e.g., the spinal cord).
Explanatory variables: features of patients and plans
To assess what information can be available for historical patients, we considered the Dutch records of the Emma Children's Hospital/Academic Medical Center childhood cancer survivor cohort, who underwent RT between 1966 and 1996 (van Dijk et al 2010 . For this cohort, along with historical patient records and treatment plan details, 2D coronal radiographs were consistently taken, hence providing partial information on the anatomy.
The complete set of features considered in this work is reported in Table 1 . Note the absence of height and weight (which are used by some phantom-based methods (Geyer et al 2014) ). For 12% of the patients, height and/or weight data were missing and preliminary experiments using automatic imputation methods showed no benefit in including them.
For the features related to anatomical geometry, anatomical landmarks from DRRs were detected automatically using the landmark detection method in our previous work (Wang et al 2020) . Note that the landmarks concerned only bony anatomy because other internal anatomy tissues are not reliably visible in historical radiographs. Importantly, we normalized features related to measurements of anatomy and anatomy-plan geometry configuration (e.g., rib-cage width, field sizes, distances between landmarks and the isocenter) by the width and height of the respective DRR they were measured from (after the DRRs were cropped to a same region of interest between T10 and S1). This was done because when plans are emulated, they are scaled based on proportions derived from the landmarks (Wang et al 2018 , Wang et al 2020 . Since differences in anatomy solely due to overall anatomy scaling do not result in different dose-volume metric values, these differences should not be accounted for by the explanatory variables (confirmed in preliminary experiments).
The abdominal diameter in AP (Diam IC AP ) is the only anatomical feature not measurable from DRRs generated along AP/PA direction. In historical RT, it was measured using a ruler to determine the isocenter position along the AP axis, and was subsequently reported in the records. For our cohort, Diam IC AP was not reported in the records because a CT scan was used for RT planning. We therefore measured Diam IC AP automatically on the CT scans, by using a pre-determined isocenter position of typical abdominal flank irradiation plans. In particular, the intervertebral disk between the 1 st and the 2 nd lumbar vertebra (L1 and L2) was used to determine the isocenter position along the inferior-superior (IS) axis, and the center of mass of the kidney was used to determine the isocenter position along the RL axis (as the aim of Wilms' tumor plans is to irradiate the renal fossa). For CTs including both kidneys, two Diam IC AP were measured, and the average was taken. Conversely, only one Diam IC AP was measured for CTs including a single kidney.
In our simulations we used for all artificial plans the same fractionation scheme (8 × 1.8 Gy), beam energy (6 MV), and prescribed dose (14.4 Gy at isocenter). These settings are the most common in historical records, and are still valid in the current Wilms' tumor RT protocol (van den Heuvel-Eibrink et al 2017). Moreover, choosing a specific prescribed dose (e.g., 14.4 Gy) does not limit generalizability, since the dose distribution over the entire anatomy depends linearly on the prescribed dose. Thus, if dose reconstruction for a historical case using a different prescription is needed, the dose-volume metrics predicted by the models trained on plans with a 14.4 Gy prescribed dose can be re-scaled. For both fields with and without a block, the features representing field sizes in RL and IS directions (W Field and L Field ) were set by simply considering the full rectangular area (i.e., irrespective of blocking). For fields with a block, the slope of the block (note that the block is formed by Multi-Leaf Collimators (MLCs)) and the ratio between the blocked region and non-blocked region of the field (Ratio Block ) was computed. In addition, we considered features that relate to how the plan was configured with respect to the patient's anatomy, based on the position of the isocenter and of the bony landmarks. For instance, ∆ IC RL (T 10 B ) links the bottom of the T10 vertebra to the position of the isocenter in RL direction. Figure 4 shows an example of the anatomical landmarks and plan geometrical borders used to calculate features describing plan configuration with respect to the patient's anatomy.
Dataset for supervised learning
Features and dose-volume metrics were finally collected in a dataset. The dataset corresponded to a 2D matrix, where the rows represented patient-plan combinations, i.e., examples (n = 42, 600), and the columns represented features (33) and response variables (4 for each OAR).
Machine learning
In the following sections we describe how ML was performed in terms of training and validation on the artificial plans. We further introduce the ML algorithm adopted, and describe an independent validation on clinical cases. 2.4.1. Training and evaluation of ML models Since dose metrics are scalars, we treated the learning problem as a regression problem. We trained a separate ML model for each combination of dose-volume metric and OAR. Preliminary analysis showed that right-sided plans and left-sided plans led to markedly different distributions of possible dose-volume metric values for all OARs except for the spinal cord. Thus, ML models were set to be composed of two submodels, each to be trained independently on a particular sub-set of the data based on plan side (right or left).
The quality of the models was estimated with a 5-fold cross-validation. This means that a random partition of 1/5th of the total number of patients and plans was held out (test set), and training was performed on the remaining data. Then, the prediction error was measured on the test set. This process was repeated five times, each time considering a different data partition for the test set. No patient nor plan that was in the test set was included in the data at training time.
Each training step included hyper-parameter tuning by grid-search with internal 5fold cross-validation (upon the training set), as well as feature selection (which resulted in eight features being systematically discarded, see the supplementary material A). For each dose-volume metric k ∈ {D mean , D 2cc , V 5Gy , V 10Gy }, the Root Mean Square Error (RMSE) loss was used, i.e.,
where Y k are the ground truth values andŶ k are the model predictions for the dosevolume metric k, and ν is the total number of rows in the training set. The RMSE was chosen to regularize ML, i.e., to penalize larger errors more (Bishop 2006) . To account for the stochastic nature of the ML algorithm employed (see Sec. 2.4.2) and for the random partitioning of the data, the 5-fold cross-validation was repeated ten times. The averages and standard deviations over the 5 × 10 validation results (five folds repeated ten times) were considered.
To put the results of ML into perspective, for each cross-validation, a baseline prediction was considered that simply used the average dose-volume metric observed in the training data. The Wilcoxon signed-rank test was used to assess whether the results obtained by ML and by this baseline are significantly different (p-value < 0.05).
Machine learning algorithm
The recently introduced Genetic Programming version of the Gene-pool Optimal Mixing Evolutionary Algorithm (GP-GOMEA) was considered as ML algorithm, as it was found to achieve competitive performance on a variety of benchmark problems , Virgolin et al 2020a , as well as in previous work concerning radiotherapy (Virgolin et al 2018a .
In addition, GP-GOMEA can perform symbolic regression, i.e., it can generate a regression ML model in the form of a (symbolic) mathematical expression. GP-GOMEA incorporates Information Theory methods that enable it to synthesize fairly accurate expressions of particularly compact size, an aspect that makes these expressions lightweight and fast to execute, and that can aid human-interpretability. Details on the hyper-parameters (and their tuning) adopted in GP-GOMEA are described in the supplementary material B.
Independent evaluation on clinical plans
As aforementioned, the 300 plans used to cross-validate our approach were generated with an automatic sampling procedure (Sec. 2.2). To assess whether our results on artificial plans can be valid for clinically-used plans, we further evaluated our approach on an independent dataset for which clinical plans were crafted manually.
For this validation, we trained ML models (as a reminder, one model per OAR -dose-volume metric combination) on the dataset using the 142 CTs and the 300 artificial plans, and evaluated their prediction accuracy on a separate set of five CTs each associated with two clinical plans. We gathered five clinical plans (three right-sided, two left-sided) for these five CTs. Under the supervision of an experienced pediatric radiation oncologist (B.V. Balgobind), two adapted versions of each plan were manually created that both had the isocenter in the middle of the fields. In one plan no block was used and in the other plan a block was introduced to protect part of the liver or spleen, depending on the plan side. Training (including 5-fold cross-validation to determine the best hyper-parameter settings) and validation were repeated ten times to account for the stochastic nature of GP-GOMEA. Averages and standard deviations were computed over these ten repetitions.
Results
Dose-volume metric data distribution
Among the 300 artificial plans, plan side and OAR type was found to influence the distribution of a dose-volume metric considerably. To illustrate the effect of OAR type and plan side on the dose, Figure 5 shows the distributions found for D mean and D 2cc for the liver and the spleen, in case of left-and right-sided plans. For D mean for the liver, distributions approximately resembling the normal distribution were obtained (in case of right-sided plans with particular high variance and long left tail). The distribution in case of right-sided plans had a mean of 9.5 Gy (typically a major part of the liver was in-field), the distribution in case of left-sided plans had a mean of 3.4 Gy (typically a minor part of the liver was in-field). In terms of D 2cc , for the liver we observed values close to the prescribed dose (14.4 Gy) both in case of left-and right-sided plans. The distributions of D mean and D 2cc for the spleen associated with the different plan sides had more marked differences than the ones for the liver. In case of right-sided plans, values close to 0 Gy were obtained for both metrics (typically the spleen was outside the field). For left-sided plans, large values of D mean were found to be much more frequent than low values. The distribution of D 2cc exhibited a peak around the prescribed dose. For the contralateral kidney and for the spinal cord the distributions are similar for both plan sides, as the contralateral kidney should be outside the field and the spinal cord should be included within the field (according to protocol).
For all OARs, distributions obtained for V 5Gy and V 10Gy largely resembled the ones obtained for D mean . In fact, Pearson correlation coefficients above 98% were found when comparing D mean with V 5Gy and V 10Gy for almost all OARs. Smaller (yet still large) correlation coefficients were found between D mean and V 10Gy for the left and right kidney, with values of 96% and 91% respectively. 
Validation on artificial plans
For each considered OAR, the Mean Absolute Errors (MAEs) (and standard deviation) at validation time for D mean , D 2cc , V 5Gy , and V 10Gy from the ten repetitions of the 5-fold cross-validation procedure using the artificial plans are reported in Table 2 . We further present the average decrease in MAE when using ML compared to when using the baseline (i.e., the effect size), as well as the outcome of statistical significance tests (Wilcoxon signed-rank) comparing ML to the baseline.
The errors for D mean and D 2cc were generally below 2 Gy, which corresponds to approximately 14% of the prescribed dose of 14.4 Gy. For all OARs but for the spinal cord, the plan side had considerable impact on the magnitude of the errors. As the spinal cord in RL direction was in-field no matter the plan side, the MAEs of dosevolume metrics predictions were found to be small: < 1 Gy for D mean and D 2cc , < 4% for V 5Gy and V 10Gy . For OARs that were almost out-of-field, e.g., the spleen in case of right-sided plans, small MAEs of D mean were found (< 0.1 Gy), as very low values were obtained across all patient-plan combinations (see Fig. 5 ). Note that in this case (and also for the D 2cc for the liver in both left-and right-sided plans), ML performs significantly but not substantially better than the baseline.
For the liver in case of right-sided plans, and for the spleen in case of left-sided plans, larger MAEs were found (liver: 1.7 Gy for D mean , 12.1% for V 5Gy , 12.6% for V 10Gy ; spleen: 1.5 Gy for D mean , 9.3% for V 5Gy , 10.7% for V 10Gy ). These errors can be attributed to the particular configuration of the position of these OARs and the field of the plans.
Among the dose-volume metrics, D 2cc for the (partly) in-field OARs had low variability, with a D 2cc close to the prescribed dose (14.4 Gy). For example, small errors were obtained for the D 2cc for the liver (< 0.4 Gy), as we consistently obtained a large D 2cc value for both left-and right-sided plans (see Fig. 5 ). In contrast, D 2cc was harder to predict when the OAR was contralateral to the plan side. The MAEs obtained for D 2cc for the spleen in case of right-sided plans was 1.6 Gy. This was 2.9 Gy for the left kidney, and 1.4 Gy for the right kidney.
The largest average error was found for D 2cc for the left kidney, amounting to 20% of the prescribed dose. For all dose-volume metrics for the right kidney, and for D 2cc for the spleen, we found that ML predictions were slightly worse compared to using the baseline (note the negative effect sizes), but not significantly so. Lastly regarding the kidneys, although errors in D 2cc were relatively large, errors in V 10Gy were relatively small (compared with V 10Gy for the other OARs). In fact, only a small percentage of the contralateral kidney, from 0 to less than 3% typically received at least 10 Gy.
Although not reported in Table 2 , we remark that the errors were found to be unbiased: no systematic over-nor under-estimations of dose-volume metrics were found on average, with the mean (non-absolute) error being close to zero for all metrics. Table 2 . Mean test MAE ± standard deviation and effect size (in small font) against the baseline (MAE of baseline -MAE of ML), of ten repetitions of 5-fold crossvalidation for each OAR and dose-volume metric on the artificial plans. Bold results are significantly better than the baseline (the opposite is never found).
Side
OAR
Right ( Figure 6 and Figure 7 show, for each clinical case, the ground truth dose-volume metric values and the predictions obtained by the ML models (trained on the artificial plans). Results for D mean and D 2cc are presented in Figure 6 , and results for V 5Gy and V 10Gy are presented in Figure 7 . The errors in D mean between predictions and ground truth values were generally low, totalling an average of 1.0 Gy (with a range of 0.0-4.9 Gy) across all OARs. Compared to the results obtained in the cross-validation using the artificial plans (Table 2) , for the liver in case of right-sided plans, the average error on the clinical plans was found to be smaller (1.2 Gy vs. 1.7 Gy). Similar average errors in D mean were found for the kidneys (0.8 Gy vs. 0.6 Gy for the left kidney and 0.5 Gy vs. 0.6 Gy for the right kidney), the liver in case of right-sided plans (1.0 Gy vs. 1.7 Gy), and the spinal cord (0.4 Gy vs. 0.4 Gy). Larger average errors in D mean were found for the spleen (0.5 Gy vs. 0.1 Gy in case of the right-sided plans and 3.6 Gy vs. 1.5 Gy in case of left-sided plans). The largest error of 4.9 Gy was found for the spleen of case P L2B (1.9 Gy error found for the spleen of case P L2 ), indicating that the impact of the block on the plan was not well modeled. Furthermore, the error in spleen D mean of P L1 and P L1B was large (2.8 Gy and 4.7 Gy, respectively), indicating both field types (without and with a block, respectively) were not well modeled for this case (see the discussion in Sec. 4).
Independent validation on clinical plans
Regarding D 2cc , similar results to the ones obtained on artificial plans were found for the spinal cord, where an average error of 0.1 Gy was obtained in D 2cc (with a range of 0.0-0.4 Gy). For the spleen of cases P R1 and P R1B , large errors in D 2cc were found (12.3 Gy on average), as ML predictions essentially wrongly represented the spleen to be out-of-field. Whereas this was the case for P R2 and P R2B , and for P R3 and P R3B , where small errors were obtained (1.1 Gy on average). Similarly, large errors in D 2cc were found in some cases for the contralateral kidneys (e.g., the left kidney: 5.1 Gy on average, with a range of 0.5-7.6 Gy). Figure 6 . Mean and standard deviation of predictions across ten repetitions for the dose-volume metrics D mean and D 2cc of the ten clinical plans. A plan-patient combination is encoded by color, and presence or absence of blocking is encoded by marker shape. Note that different plots have different scales of the vertical axis. For each case, the ground-truth dose-volume metric is indicated by a red square. In each plot, the first six cases (white background, plan subscripts starting with 'R') are rightsided plans, the last four cases (gray background, plan subscripts starting with 'L') are left-sided plans.
Results for V 5Gy (average error 8% with a range of 0-35%) and V 10Gy (average error 7% with a range of 0-49%) mostly followed the trend of the errors for D mean , as these metrics were found to be correlated for most OARs. Figure 7 . Mean and standard deviation of predictions across ten repetitions for the dose-volume metrics V 5Gy and V 10Gy of the ten clinical plans. A plan-patient combination is encoded by color, and presence or absence of blocking is encoded by marker shape. Note that different plots have different scales of the vertical axis. For each case, the ground-truth dose-volume metric is indicated by a red square. In each plot, the first six cases (white background, plan subscripts starting with 'R') are rightsided plans, the last four cases (gray background, plan subscripts starting with 'L') are left-sided plans.
Discussion
In this article we presented a new and different paradigm in organ dose reconstruction. By leveraging the modeling power of ML, we showed how patient and plan features can be used to predict organ dose-volume metrics directly, without the need of adopting a surrogate anatomy. Once the ML models are trained, they can readily be used to compute dose-volume metric predictions for a new historical patient and plan, by using their features as input.
Key to obtaining a decent amount of data to perform ML were the collaboration of five international institutes to gather pediatric patient CTs (147), the development of a new automatic sampling procedure yielding artificial Wilms' tumor RT plans, and the creation of an automatic dose reconstruction pipeline to calculate the dose for all patient and plan combinations. We validated our approach on 300 automatically generated artificial plans, and on ten manually created clinical plans, to assess whether the results of the validation on the artificial plans generalize well in practice. Our approach showed promising levels of accuracy in dose reconstruction in both settings.
Errors were found to be overall similar between the validation on the ten clinical plans and the validation on the artificial plans. However, for some metrics, errors were larger for the ten clinical plans. This may be due to chance, because ten is a small number to validate upon. Another possibility is that the artificial plan generation method needs to be improved. Artificial plans were generated by sampling geometry properties uniformly within predefined boundaries on two reference DRRs. Uniform sampling might not be representative of the distribution clinical plans have. Moreover, we consulted a single radiation oncologist to define clinically acceptable boundaries to use in the sampling of artificial plans. Consulting multiple experts and allowing for a larger variation might better help covering the extent of variation that is present in historical plans (Sec. 2.2). For example, the isocenter locations of artificial left-sided plans were never sampled below the 1st lumbar vertebra (see Fig. 2 ) and approximately half of the D mean values for the spleen in case of the artificial left-sided plans were close to the prescribed dose (14.4 Gy, see Fig. 5 ), which means that the spleen was often almost completely in-field in our artificially generated set of left-sided plans. When a block was applied, only a small part of the spleen was spared. However, in clinical practice, isocenter locations can be lower, and a larger part of the spleen might actually be outside the field (see Fig. 8 ). This might explain the relatively large errors observed in Figure 6 for P L1B and P L2B where the isocenter location is lower than the sampled range. Ultimately, effort should be done to improve the sampling of artificial plans.
In the validation performed upon artificial plans as well as in the one performed upon clinical plans, a main result that emerges is that dose-volume metrics for an organ are hard to predict when, due to the field setup, it is unclear whether the OAR is (partially) included in the field or not. For example, consider the D 2cc as opposed to the D mean for the spleen for P R1 and P R1B in Figure 6 : a tiny part of the spleen being inside the field causes a large D 2cc (wrongly predicted to be small), and small D mean Figure 8 . Effective field shape of plans P L1 (on the upper left), P L1B (on the upper right), P L2 (on the lower left) and P L2B (on the lower right) plotted on top of the associated DRR. The fields are placed lower than most of the sampled artificial plans (see Fig. 2 ) and consequently a (large) part of the spleen (indicated by the light blue contours) is outside the field (for P L1B and P L2B an even larger part of the spleen was blocked).
(correctly predicted to be small). As experimentally observed in prior work (Virgolin et al 2018b , 2D bony anatomy provides only coarse information on OAR shape and position even for ML algorithms (e.g., an MAE of 6.4 mm for the prediction of the liver position along the IS axis was reported ). Yet, because bony anatomy is the only structure that is reliably visible in historical radiographs, most of the anatomical features rely on it. Patients with similar anatomical features derived from bony anatomy may have different OAR shape and position, and thus different dose-volume metrics. Furthermore, impreciseness in feature values due to e.g., uncertainties in landmark detection and plan emulation, aggravate the situation.
Compared to conventional dose reconstruction methods (that use surrogate anatomies and heuristics to decide what surrogate to use), we considered a relatively large number of features: 33. Phantom-based methods consider, e.g., only age and gender (Stovall et al 2006 , Howell et al 2019 , or gender together with height and weight percentiles (Geyer et al 2014) . However, if a 2D radiograph is available, the added value of this information should be exploited. In our work, the majority of the features we considered, i.e., 23 out of 33 (minus eight due to automatic feature selection, see supplementary A), regarded patient anatomy as visible on a 2D radiograph, which we simulated with DRRs. Our DRRs were generated in a conformal fashion, e.g., the abdomen was always fully included in RL direction. The automatic landmark detection that was used to generate features expects this conformity to achieve precise detection (Wang et al 2020) . When dealing with actual historical radiographs, however, several challenges need to be taken into account. For example, our automatic landmark detection method requires further development to account for noise in the radiograph (e.g., the presence of hand-writing on the radiograph). Moreover, educated guesses of landmark locations may be needed in some cases, as some historical radiographs do not include the entire abdomen (see Fig. 1(c) ). Nevertheless, as long as the features are somehow collected (e.g., manually), they can be used as input for the ML models to get respective dose-volume metric predictions.
There are disadvantages of our approach compared to conventional dose reconstruction methods that use surrogate anatomies beyond the need for patient radiographs, which are not always available in retrospective data. In particular, a key limitation is that ML models do not predict the entire 3D dose distribution an organ receives, but only the metrics they were trained for. Potentially useful information to link to AEs may be contained in 3D dose distributions. To predict 3D dose distributions, the ML models would need to be trained to predict a 3D output. Surrogate-based methods do allow to obtain the entire 3D dose distribution to an organ, since the distribution can be visualized on the organ of the surrogate anatomy, after plan simulation. However, considering the magnitude and variations of the errors of organ mean dose obtained by conventional approaches (Wang et al 2018) , it is questionable whether the full 3D distribution will be sufficiently reliable. Our approach, as currently proposed, can straightforwardly be extended to predict any (scalar) dose-volume metric that is suspected to be useful to study AEs (it suffices to train ML on that metric).
Another limitation of our approach is that it does not take into consideration uncertainties related to OAR motion. For validation, we aimed at reconstructing the dose based on the particular snapshot of anatomy at the moment the CT (ground-truth) / respective DRR (to simulate historical radiographs) was taken. Yet, OAR motion plays a key role in the uncertainty of organ positioning at the edge of the field, which can lead to a discrepancy between the planned dose and the actual delivered dose. In RT practice, radiation delivery is performed over a number of days, with fractionation schemes. The OAR position can therefore vary (i.e., inter-fractional position variation). Intrafractional organ motion due to, e.g., respiration variation, contributes to the difference between planned dose and delivered dose as well (Huijskens et al 2015) .
Lastly, a main limitation of our approach is that the ML models we generated are specific to pediatric patients (1 to 8 years of age) and Wilms' tumor RT plans: they can only predict reliable dose-volume metrics of specific OARs they were explicitly trained for. The RT plans we have sampled were also restricted to a standard AP-PA setup without considering wedges, boost fields, or other radiation sources such as Cobalt-60. Moreover, the predictions of the ML models (as well as the validation performed in this study) are based on the dose calculation algorithm we adopted when preparing training data, which has inaccuracies. Specifically, we used a collapsed cone algorithm available in Oncentra TPS. Though good accuracy was reported in the in-field and near-field region (< 5 cm from the field borders, achieves an error of 1-2% of the prescribed dose), in low dose regions (10-15 cm from the field border) an underestimation of 10% of the dose in the region was reported (Krieger and Sauer 2005) . We remark that the OARs we considered in this study were mostly within 5 cm near the field border (except for the spleen in case of the right-sided plans). To make the method more general for OARs far from field borders, more advanced Monte Carlo dose calculation algorithms should be applied in future implementations. However, we believe that the core ideas of our work can be replicated for other cohorts and other types of plans. Essentially, as long as a sufficient number of anatomies and plans are collected or generated, and a large number of dose reconstructions are performed to be used as examples, new ML models can be trained to predict how the dose-volume metrics are linked to anatomyplan configurations. As was the case in our study, the collection and preparation of sufficient data for ML is likely to be the largest required effort.
Our proposed approach presents several advantages compared to traditional dose reconstruction methods. First of all, we found our validation results to compare favorably with respect to our recent work considering dose reconstruction for a similar childhood cancer cohort (Wang et al 2018) . The work considered 31 patients aged 2 to 6, 12 Wilms' tumor clinical plans, and a total of 50 dose reconstruction combinations, which were performed by matching a surrogate CT based on age and gender. The work reported an MAE for the D mean for the liver of 1.6 Gy (average across both leftand right-sided plans), and an MAE for the D mean for the spleen of 2.6 Gy. For the liver, we obtained an MAE of 1.3 Gy when validating on artificial plans, and of 1.1 Gy when validating on ten clinical plans. For the spleen, we obtained an MAE of 0.8 Gy on artificial plans, and of 1.7 Gy for the clinical plans. Furthermore, our ML-based predictions resulted in much smaller variations. The inter-quantile range (25th to 75th percentile) of the (non-absolute) prediction error of our previous work was 3.6 Gy for the liver, and 4.7 Gy for the spleen (Wang et al 2018) . On the artificial plans, we obtained a range of 2.0 Gy for the liver, and of 1.2 Gy for the spleen. On the clinical plans, the range for the liver was 1.9 Gy, and the one for the spleen was 2.2 Gy. We remark that since the dose reconstruction accuracy is largely influenced by the particular plans considered, these values may not be a fair comparison. We are currently working on a multi-institute study to compare our approach with two state-of-the-art, phantom-based dose reconstruction approaches (Lee et al 2015 , Howell et al 2019 . In that study, a same set of patients and plans will be used for validation.
Finally, a benefit of having ML models is that, once features are collected, they can be used as inputs for the model to obtain the prediction of a dose-volume metric immediately. Running a model on a computer simply means to follow the steps encoded by the formula the model represents, which takes a few milliseconds. Conversely, in a surrogate-based approach, the features are used to craft or select a surrogate anatomy. Then, effort and time must be put to emulate the plan on the surrogate anatomy, calculate the dose, and obtain the dose-volume metrics (Lee et al 2015 , Howell et al 2019 , Wang et al 2020 .
Conclusion
We presented the first surrogate-free organ dose reconstruction method based on ML. Our method was enabled by the collection of large amounts of patient and CT data, and the automatic generation of artificial plans and of dose distribution data. We assembled a dataset of dose-volume metrics corresponding to features of patient anatomy and plan geometry, and subsequently trained ML models to predict how features of patient anatomy and of treatment plans influence dose-volume metrics. The predictions were validated upon both artificial and clinical RT plans, and achieved good accuracy in both cases. 
B. Hyper-parameters of GP-GOMEA and their tuning
The hyper-parameters of GP-GOMEA are reported in Table 1 . A short description follows.
Tree height. GP-GOMEA encodes machine learning models with symbolic trees . In our case, trees were binary. The maximal tree height of a tree limits how complex the encoded machine learning model can be. For instance, a tree with height 2 can contain up to 7 nodes, a tree with height 4 can contain up to 31 nodes. Larger trees can encode relatively complex models (but risk overfitting), smaller trees can encode relatively simple formulas (but risk underfitting).
Evaluations limit. The evaluations limit is used to terminate GP-GOMEA. An evaluation is the computation of the loss function of a model. Terminating early/late can be useful to prevent overfitting/underfitting. Function set. The atomic components that can be instantiated as nodes can be features (of Table 1 of the manuscript), random constants, or functions from a predefined function set. Random constants are sampled uniformly at random between {−ρ, +ρ}, where ρ := 5 × max(x), and x is the 2D matrix containing all numerical feature values for all patients and plans (in the training set). We considered a simpler function set of algebraic functions ([+, −, ×, ÷ p ]), and a more complex one including trigonometric and transcendental functions ([+, −, ×, ÷ p , · 2 , | · |, sin, cos, exp]}). More complex functions can help fit the data better, at the risk of overfitting.
Interleaving generations & starting population size. Whereas typical GP algorithms perform a single evolutionary run, GP-GOMEA uses a scheme of multiple runs of increasing evolutionary budget. Larger-budget runs are started later in the scheme, and executed in an interleaved fashion such that smaller-budget runs perform more iterations (called generations) than larger-budget runs. The first run r 1 uses the starting population size and executes g generations before the next run r 2 is started. The run r 2 has a population size that is double of that of r 1 (1000), and performs 1 generation every g generations of r 1 . The first time r 2 has executed g generations, r 3 is started, with double the population of r 2 (2000). Subsequently, r 3 will execute 1 generation every time r 2 has executed g generations. If a run converges to all identical machine learning models, then it is terminated. A run is also terminated if a larger-budget run exists that has found a better machine learning model.
As shown in Table 1 , we used a starting population size of 500 and a number of generations for interleaving g = 6. These choices are based on what is reported in our previous work , except for the starting population size (set to 50 in the article), as the article shows that runs with population sizes below a thousand are typically terminated anyway within the first couple of minutes. Hence, computations performed by those runs are essentially wasted. We set g = 6 because it is the intermediate value (between 4 and 8) considered in our previous work , and because GP-GOMEA is fairly robust to the choice of g, i.e., the results for g = 4 are similar to the ones of g = 6 and g = 8.
